IDELALISIB for Non-hodgkin's lymphoma unspecified histology indolent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 164 adverse event reports in the FDA FAERS database where IDELALISIB was used for Non-hodgkin's lymphoma unspecified histology indolent.
Most Reported Side Effects for IDELALISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 1,204 | 17.6% | 139 | 130 |
| Death | 779 | 11.4% | 779 | 117 |
| Diarrhoea | 752 | 11.0% | 87 | 510 |
| Off label use | 548 | 8.0% | 85 | 159 |
| Pneumonia | 426 | 6.2% | 140 | 311 |
| Pyrexia | 371 | 5.4% | 44 | 290 |
| Drug ineffective | 294 | 4.3% | 62 | 63 |
| Fatigue | 284 | 4.1% | 29 | 132 |
| Dehydration | 242 | 3.5% | 22 | 212 |
| Dyspnoea | 206 | 3.0% | 41 | 143 |
| Neutropenia | 204 | 3.0% | 47 | 100 |
| Colitis | 201 | 2.9% | 41 | 133 |
| Pneumonitis | 199 | 2.9% | 57 | 133 |
| Asthenia | 193 | 2.8% | 22 | 138 |
| Rash | 168 | 2.5% | 27 | 63 |
Other Indications for IDELALISIB
Chronic lymphocytic leukaemia (3,537)
B-cell lymphoma (1,240)
Product used for unknown indication (551)
Non-hodgkin's lymphoma (373)
Lymphoma (301)
Follicular lymphoma (200)
Waldenstrom's macroglobulinaemia (88)
Leukaemia (74)
Diffuse large b-cell lymphoma (66)
B-cell small lymphocytic lymphoma (65)
Other Drugs Used for Non-hodgkin's lymphoma unspecified histology indolent
BENDAMUSTINE (245)
RITUXIMAB (222)
OBINUTUZUMAB (115)
CYCLOPHOSPHAMIDE (67)
VINCRISTINE (63)
DOXORUBICIN (54)
PREDNISONE (54)
LENALIDOMIDE (38)
CYTARABINE (23)
DEXAMETHASONE (23)